BDBM504289 (4S)-3′-[2,6-Difluoro-4-(2-phenylethynyl)phenyl]-1′-methyl-spiro[5,6,7,8-tetrahydro-1H-cyclohepta[c]pyrazole-4,6′-hexahydropyrimidine]-2′,4′-dione::US11034699, Example 15
SMILES: CN1C(=O)N(C(=O)C[C@]11CCCCc2[nH]ncc12)c1c(F)cc(cc1F)C#Cc1ccccc1
InChI Key:
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM504289![]() ((4S)-3′-[2,6-Difluoro-4-(2-phenylethynyl)phe...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 54 | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description A monoclonal HEK-293 cell line stably transfected with a cDNA encoding for the human mGlu4 receptor was generated; for the work with mGlu4 Positive A... | US Patent US11034699 (2021) | |||||||||||
More data for this Ligand-Target Pair |